Curis, Inc. , a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
Curis stock last closed at $1.35, up 0% from the previous day, and has decreased 65.82% in one year. It has underperformed other stocks in the Biotechnology industry by 0.19 percentage points. Curis stock is currently +32.35% from its 52-week low of $1.02, and -70% from its 52-week high of $4.50.
As of Dec 5, 2025, there are 12.93M shares of CRIS outstanding. The market value of CRIS is $17.45M. In the last 24 hours, 103,000 CRIS shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy CRIS stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to invest in CRIS today.
Now that you have created your account on the best free stock trading app, you can securely and quickly fund your account:
Check out the video below to see the process of depositing funds into your investment account.
After you have figured out the best place to buy Curis stock, it's very important to analyze their stock before you invest, so you actually wrap your head around the risk as well as the upside.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on CRIS's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRIS's true value.
You can access additional valuation research on CRIS's stock here.
You can dive deeper into what analysts are projecting on the Curis stock forecast page.
Last year, CRIS revenue was $11.65M. In the past five year, CRIS's revenue has gone up by 0.98% per year. This was slower than the Biotechnology industry average of 44.12%.
Dig into CRIS's earnings and revenue performance here.
In the last 12 months, insiders at CRIS have not bought or sold any shares.
Research more about who owns CRIS shares here.
No, Curis doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary order types:
Press the Open Trade button and eToro will place the order.
If you require additional help with investing in stocks on eToro, click the helpful video below:
Now that you own some CRIS shares, you'll want to keep up with your new stock purchase.
Put CRIS on a watchlist to monitor your CRIS stock.
To summarize, here are the 6 steps to buy Curis stock:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your investment in Curis, create a watchlist on WallStreetZen today.